Wellisch Alejandro D 4
4 · ABBOTT LABORATORIES · Filed Feb 26, 2019
Insider Transaction Report
Form 4
Wellisch Alejandro D
Senior Vice President
Transactions
- Award
Option (right to buy)
2019-02-22+81,578→ 81,578 totalExercise: $75.90From: 2020-02-22Exp: 2029-02-21→ Common shares (81,578 underlying)
Footnotes (1)
- [F1]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 27,192 on February 22, 2020, 27,193 on February 22, 2021, and 27,193 on February 22, 2022.